FDA Approves First 1-Minute HIV Self-Test, Revolutionizing At-Home Diagnostics
核心洞察
The FDA has approved the Insti HIV Self Test (搜索) from bioLytical Laboratories, marking the first 1-minute HIV (搜索) self-test available in the United States.
The test requires only a drop of blood from a fingertip and delivers results in 60 seconds with 100% sensitivity and 100% specificity compared to standard laboratory tests.
This breakthrough addresses critical gaps in HIV (搜索) screening for the estimated 1.2 million Americans living with HIV, particularly the 13% who remain undiagnosed.
The U.S. Food and Drug Administration has approved the Insti HIV Self Test (搜索) from bioLytical Laboratories Inc (搜索)., making it the first one-minute HIV (搜索) self-test available in the United States. This groundbreaking diagnostic tool represents a significant advancement in HIV testing accessibility, requiring only a single drop of blood from a fingertip to provide highly accurate results in just 60 seconds.
Addressing Critical Public Health Needs
HIV (搜索) remains a serious public health challenge in the United States, with approximately 1.2 million Americans living with the virus. Critically, around 13% of individuals living with HIV do not know they have it, emphasizing the urgent need for expanded testing and early detection to improve treatment options and reduce transmission risk. Over 30,000 new infections occur annually in the U.S., with most new HIV infections coming from individuals who are unaware of their status.
"HIV (搜索) testing should be simple, fast, and accessible for everyone," said Robert Mackie, CEO of bioLytical. "By offering accurate results in just 60 seconds, we are empowering people to take control of their health without waiting for clinic appointments or lab results."
Superior Performance and Accessibility
The Insti HIV Self Test (搜索) addresses significant gaps in screening for patients who experience barriers to traditional healthcare testing for HIV (搜索), including stigma, cost, or location. The portable and discreet test allows patients to privately self-test on their own terms, providing a convenient alternative to clinic-based testing.
Data supporting the FDA approval demonstrated exceptional performance, with the self-test showing 100% sensitivity and 100% specificity compared with a fourth-generation HIV (搜索) antigen/antibody enzyme-linked immunosorbent assay (ELISA). Field studies revealed that 95% of patients believed the self-test was easy to use, would use it again, and would recommend it to family members and partners.
The test was previously prequalified by the World Health Organization in 2018 and is based on the Insti HIV (搜索)-1/HIV-2 antibody tests that were approved by the FDA, Health Canada, and WHO as the only rapid HIV test with such performance characteristics.
Supporting National HIV Prevention Goals
This approval aligns with the CDC (搜索)'s ambitious public health goal of Ending the HIV (搜索) Epidemic (EHE), which aims to reduce HIV infections by 90% by 2030 using four science-based strategies: diagnose, treat, prevent, and respond. The initiative emphasizes using the latest systems and technology and applying novel approaches to make HIV testing more accessible.
"The FDA approval of the Insti HIV Self Test (搜索) reflects both the scientific integrity of our work and our commitment to expanding access to rapid, reliable diagnostics," said Ana Subramanian, Vice President of Scientific Affairs at bioLytical. "This milestone ensures that more people across the US can confidently access accurate HIV (搜索) testing when and where they need it most."
Clinical Impact and Historical Context
Since the 1980s, HIV (搜索) incidence has decreased significantly, with the highest number of infections (130,400) occurring in 1984 and 1985, decreasing to 34,800 in 2019. Annual infections in the US have been reduced by more than two-thirds since the height of the epidemic in the mid-1980s. The CDC (搜索) attributes this decline to increases in pre-exposure prophylaxis prescriptions, viral suppression, and HIV testing accessibility.
Early detection through testing improves treatment outcomes and significantly reduces transmission risk. Once an individual is diagnosed, the CDC (搜索) focuses on treatment strategies that support early initiation of antiretroviral therapy and provides training and educational resources to healthcare providers and patients.
Product Specifications and Availability
The test is designed as a single-use, rapid, in vitro diagnostic immunoassay for the detection of HIV antibodies (搜索), intended for users 18 years and older. According to the FDA approval letter, the device should be stored at 2°C to 30°C in the original packaging in cool and dry locations.
The company has indicated that the Insti HIV Self Test (搜索) will be available at major retailers and online soon as an over-the-counter product. bioLytical will manufacture the test in its state-of-the-art facility, ensuring the highest quality standards through its MDSAP: ISO 13485:2016 Quality Management System.
"By breaking down barriers to testing, we are helping more people take control of their health," Mackie emphasized. "This test is a powerful tool in the fight against HIV (搜索), providing immediate answers when they matter most."